Chinese producers prevail in VC Antitrust Litigation with the US

On 20 Sept., 2016, the U.S. Court of Appeals issued its decision to vacate the USD147 million treble damage judgment to 2 Chinese vitamin C (VC) producers, North China Pharmaceutical Co., Ltd. (North China Pharmaceutical) and Hebei Welcome Pharmaceut...

Vitamins China E-News 201609

www.cnchemicals.com